PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Klöckner Pentaplast acquires packaging company Farmamak from Gözde Girişim

Montabaur, Germany – September 6, 2016 – The global rigid film producer Klöckner Pentaplast will
acquire Farmamak from Gözde Giri?im Sermayesi Yat?r?m Ortakl??? A.?. (Gözde Giri?im). Farmamak
will operate as a subsidiary within the Klöckner Pentaplast Group.
Klöckner Pentaplast, a world-leading producer of rigid films for the pharmaceutical, medical
devices, food and consumer packaging and beverages, has signed a definitive agreement to acquire
the rigid film producer Farmamak. Farmamak is a leading rigid film producer in Turkey (and the
surrounding regions) and currently resides under Gözde Giri?im.
“We are excited for our first acquisition since 2011, together – with Farmamak as a local leader –
this transaction allows us to improve our customer focus in Turkey and throughout the Middle East to
improve our regional service and capabilities.” commented Wayne M. Hewett, Chief Executive Officer,
Klöckner Pentaplast.
“Always a pioneer and innovator in its field, Farmamak introduced many industry firsts and
achieved sustainable growth over a number of years. I am sure that under the ownership of Klöckner
Pentaplast, the business will further build on this solid heritage and see further growth,” explained
Gözde Giri?im CEO Mustafa Aydemir.
Farmamak, with sales of TRY 155 million (~EUR 47 million), employs around 230 people and its
production site is located in Gebze, Turkey. “Integrating Farmamak into the Klöckner Pentaplast Group
shows great confidence in the potential of our company and our employees and brings more
opportunities in the market to unlock further growth” said Kurt Kuruç, Managing Director of Farmamak.
Through targeted portfolio adjustments, Farmamak aims to further strengthen its position as a
leading film provider in the food, consumer packaged goods and pharmaceutical segments. Together
with Klöckner Pentaplast, Farmamak offers a wider range of products and comprehensive services at a
local level.
The transaction is subject to approval by the competition authorities. Until such approval is
granted, Klöckner Pentaplast and Farmamak will operate independently.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026